Form 4: Elanco CEO Boosts Stake with DSU Acquisition

Jeffrey N. Simmons, Elanco Animal Health's President and CEO, acquired 144.2313 deferred stock units, increasing his total beneficial ownership to 17,836.142 units.

Summary

• Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc. (ELAN), acquired 144.2313 Deferred Stock Units (DSUs).
• The transaction occurred on September 19, 2025.
• Each DSU represents the right to receive one share of Company common stock or its cash equivalent.
• The DSUs settle in cash or shares following termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.
• Following this acquisition, Mr. Simmons beneficially owns a total of 17,836.142 DSUs.
• The implied price per DSU for this transaction was $19.2.

Sentiment

Score: 6

Explanation: Slightly positive due to increased insider ownership, which can signal confidence, though it's likely a routine compensation event.

Positives

• Acquisition of deferred stock units by the CEO indicates continued alignment of management's interests with shareholder value.
• Increased beneficial ownership by a key executive can be viewed as a vote of confidence in the company's future prospects.

Future Outlook

NA

Industry Context

This insider transaction is specific to Elanco Animal Health and does not directly provide broader industry trends or competitive insights. However, executive compensation structures, including deferred stock units, are common across various industries to align management incentives with long-term company performance.

Stakeholder Impact

• Shareholders: May view the increased insider ownership as a positive signal of management's commitment and belief in the company's future.

Key Dates

Keywords

Elanco Animal Health, ELAN, Jeffrey N. Simmons, CEO, Director, Insider Transaction, Form 4, Deferred Stock Units, DSU, Beneficial Ownership